The information contained in the website is solely intended for professional investors. Some funds shown on this website fall outside the scope of the Dutch Act on the Financial Supervision (Wet op het financieel toezicht) and therefore do not (need to) have a license from the Authority for the Financial Markets (AFM).
The funds shown on this website may not be available in your country. Please select your country website (top right corner) to view the products that are available in your country.
Neither information nor any opinion expressed on the website constitutes a solicitation, an offer or a recommendation to buy, sell or dispose of any investment, to engage in any other transaction or to provide any investment advice or service. An investment in a Robeco product should only be made after reading the related legal documents such as management regulations, prospectuses, annual and semi-annual reports, which can be all be obtained free of charge at this website and at the Robeco offices in each country where Robeco has a presence.
This study* shows that institutions typically trade on the wrong side of anomalies. For instance, they tend to buy growth stocks and sell value stocks, thereby going directly against the value anomaly.
The study also finds that anomalous returns are concentrated primarily in stocks with institutions on the wrong side of the implied mispricing, and argues that a behavioral explanation for these results appears to be most plausible. This may seem odd because institutions are generally thought of as ‘smart’ and well aware of the decades-old anomalies literature.
On the other hand, it is also plausible because institutional money management entails agency conflicts that have been documented before to result in suboptimal portfolio decisions, such as excessive turnover and herding for reputational reasons. Moreover, if anomalous returns are a consequence of mispricing, then the most obvious source of an impact big enough to distort asset prices is the beast with the largest footprint – institutions.
Our researchers publish many whitepapers based on their own empirical studies; they also follow quantitative research done by others. Head of Quant Equities Research David Blitz comments on notable external papers.